AGEN
AGENUS INC
NASDAQ · Healthcare · Biotechnology · US
$7.85
+8.73%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 9.64x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.89x
- PEG TTM
- —
- Price / book
- -1.78x
- Price / sales
- 2.67x
- Price / cash flow
- -3.60x
Enterprise value
- Enterprise value
- $369.7M
- EV / sales
- 2.79x
- EV / EBITDA
- 2.37x
- EV / EBIT
- 10.21x
- Market cap
- $354.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026